Revolutionary Company PathogenDx Announces $7.5 Million In Series B Funding

PathogenDX
PathogenDX
PHOTO COURTESY; PATHOGENDX

PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for cannabis, hemp, agriculture and food safety industries, announced Monday it has secured $7.5 million in Series B funding. The company was able to close this round of funding in just under three months.

Read More Here At Forbes: